Adam Havey, EVP, Biodefense Divison at Emergent BioSolutions Inc. (EBS), sold 18,991 shares at $26.96 ($514K) on 2014-03-11, disclosed to the SEC on 2014-03-12.
Seasonal sale ($514k) by EVP, Biodefense Divison — this insider has traded EBS in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.96 | 5,835 | $157K | 30.6% |
| 2 | $26.96 | 11,820 | $319K | 62.1% |
| 3 | $28.09 | 1,336 | $38K | 7.3% |
| Total | $27.04 avg | 18,991 | $514K | 100% |
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |